InvestorsHub Logo
Followers 183
Posts 30024
Boards Moderated 3
Alias Born 07/09/2003

Re: jondoeuk post# 154

Sunday, 06/26/2022 10:32:57 AM

Sunday, June 26, 2022 10:32:57 AM

Post# of 301
DTIL: 1.44 price reflects a lack of exposing deep fraud and deception, or misdirection, in the face of these realities and theories:

1- price falling violently from 2 to 1.11 because of a false material influence of another T-Cart editing platform which failed (collateral damage from CRBU data).
2-- DTIL not desperate for cash with 100 million in recurring revenue, and market cap below 100 million, before their additional 50 million underwriting share offering..
3-- Novartis affirming and validating their platform with 75 million
divy and offering 1.4 billion potential milestones.
4- CEO upping his stake by 40% with 30,000 additional share purchase @$2, days ago.
5- 50 million dollar dilutive offering@1.39 throwing off scent to dumb money but ensuring cash runway to 2024.

My theory, a cynical attempt by group to attack share price who believe (correctly) they can capture huge shares for future ante, believing technical vol. price drops rule short term investing predilections, confirming to the mob, that the dictum do not fight the tape is usually the most authoritative source consistent with implementing prudent investing behavior.

Net effect to my brain is that this is a rare "no-brainer" which defies all rules I know about investing in a stock, and a cautionary note to myself not to invest in any BIo stock because I believe in its great science without evidence of massive insider buying and affirmation by one of the top largest pharmaceutical firms with a major investment and alliance.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DTIL News